Leave Your Message
0%

Anhydrous Dextrose Injection is one of those things that helps hospitals when patients need glucose and fluids fast. But what makes it really valuable isn't just the dextrose concentration. You've also got to think about sterility, whether the container stays intact, traceability, and having a reliable supply that actually shows up when it's needed.

So, the WHO’s Good Manufacturing Practices guidance puts a lot of weight on things like validated processes, keeping contamination under control, and having solid documentation for quality systems. That stuff matters even more when you’re dealing with injectable medicines. And if you look at the FDA’s Drug Shortages Database, you can see how manufacturing hiccups can ripple out and hit essential hospital products. Bottom line: supply reliability really deserves our attention.

Market evidence? Yeah, it adds some useful context. Take IQVIA’s Global Use of Medicines 2024 report—it points to ongoing pressure on healthcare budgets, medicine availability, and supply-chain resilience. So hospitals really need suppliers who can show measurable capabilities, not just make attractive claims. And if you’re doing a serious review, you’d want to look at things like regulatory registrations, production sites, batch-release testing, packaging standards, and export experience.

So, this article takes a look at five suppliers of Anhydrous Dextrose Injection from around the world. We compare them on things like how transparent their manufacturing is, the quality certifications they have, product specs, logistics, and customer support. We also make a point to separate the direct manufacturers from the trading companies—something that often gets overlooked.

Supplier info? It can change fast. And honestly, that’s the tricky part. Certificates expire, production locations shift, and public websites often don’t show the latest evidence. Just because a label says “12 Injection” doesn’t mean it should replace a full product specification and quality review. Before buying, verify every critical document with the supplier—and with the relevant authorities, too.

Honestly, there’s no one-size-fits-all ranking for hospitals. Things like regional registration rules, the concentrations you actually need, packaging formats, and how well a supplier can handle emergency supply—all of that can shift the outcome. In the end, the strongest supplier is usually the one that pairs solid, documented quality with delivery performance you can really check and count on.

5 Best Anhydrous Dextrose Injection Suppliers Worldwide

What Is Anhydrous Dextrose Injection?

Anhydrous dextrose injection is a sterile intravenous solution containing glucose without bound water molecules. Clinicians use it to provide rapidly available carbohydrate and, in selected cases, to treat low blood glucose. It is not the same as oral sugar water. The solution enters circulation directly, requiring strict control of sterility, concentration, and infusion rate.

According to U.S. Food and Drug Administration prescribing data, common strengths include 5%, 10%, and 50% dextrose. A 5% solution supplies about 170 kilocalories per liter, while 10% provides approximately 340 kilocalories. The United States Pharmacopeia–National Formulary sets quality expectations for identity, strength, sterility, and particulate control. These details matter. A clear bag is not automatically a safe bag.

Higher concentrations are strongly hypertonic. FDA labeling warns that concentrated solutions may irritate veins and can cause tissue injury after leakage. Hospital protocols therefore consider dilution, infusion access, glucose monitoring, and patient condition. The World Health Organization’s Global Report on Diabetes recorded 422 million adults living with diabetes in 2014, showing the continuing clinical importance of glucose management. However, that figure does not define injection demand. Supplier evaluation should also examine batch testing, container integrity, cold-chain procedures where applicable, and regulatory documentation. One practical weakness remains: product descriptions often explain concentration, but omit administration risks. That omission deserves careful review.

Key Medical Uses and Formulation Characteristics

5 Best Anhydrous Dextrose Injection Suppliers Worldwide

Anhydrous dextrose injection provides rapidly available glucose through sterile intravenous delivery. Common concentrations include 5%, 10%, 20%, and 50%. A 5% solution supplies about 170 kcal per liter. Higher strengths deliver more glucose but create greater osmotic pressure. For example, 50% dextrose approaches 2,525 mOsm/L. It usually requires careful venous access and clinical monitoring.

Key medical uses include treating documented hypoglycemia, supplying short-term carbohydrate calories, and supporting selected dilution protocols. Product selection should consider sterility assurance, container integrity, endotoxin controls, and batch traceability. USP General Chapter emphasizes controlled compounding practices. The World Health Organization reports that medication errors cost approximately US$42 billion annually. That figure makes supplier verification more than a purchasing formality.

Tips: Check concentration, pH, osmolarity, expiration dating, and storage instructions. Ask for certificates of analysis and stability data. Do not assume compatibility with Vb12 Injection or other additives. Compatibility depends on concentration, container material, and administration conditions. A separate line may be safer. Procurement teams should also review recall history and shipping temperature records. Some details remain easy to overlook, especially when a clear solution looks identical across strengths. That assumption deserves challenge.

5 Best Anhydrous Dextrose Injection Suppliers Worldwide - Key Medical Uses and Formulation Characteristics

Supplier Profile Common Product Strengths Main Medical Uses Typical Administration Formulation Characteristics Typical Packaging Key Quality Requirements Selection Considerations
Supplier Profile 1 5%, 10%, and 20% dextrose injection Fluid replacement, carbohydrate supplementation, and prevention or treatment of mild hypoglycemia Intravenous infusion; concentration and infusion rate are selected according to the patient’s condition Sterile, clear, aqueous solution containing anhydrous dextrose; lower concentrations are generally less hypertonic than concentrated solutions Single-dose glass bottles, plastic infusion bags, or flexible containers Sterility, bacterial endotoxins, particulate matter, assay, pH, fill volume, container-closure integrity, and stability testing Suitable for hospitals seeking standard strengths and broad compatibility with routine infusion protocols
Supplier Profile 2 10%, 20%, and 40% dextrose injection Rapid carbohydrate delivery and treatment of clinically significant hypoglycemia under medical supervision Intravenous administration; concentrated strengths generally require controlled use and appropriate venous access Hypertonic solution with a high carbohydrate load; concentrated formulations require careful monitoring for extravasation and hyperglycemia Small-volume glass vials, ampoules, or ready-to-use plastic containers Validated aseptic processing, low endotoxin levels, concentration accuracy, visual clarity, and robust container-closure integrity Best suited to facilities requiring concentrated presentations for emergency and critical-care stock
Supplier Profile 3 5% and 10% dextrose injection Maintenance fluid support, medication dilution when compatible, and basic caloric supplementation Intravenous infusion through peripheral or central access, depending on concentration and clinical requirements Near-isotonic or moderately hypertonic presentations may be available; no antimicrobial preservative is typically required for single-dose products Large-volume flexible infusion bags or single-dose bottles Compliance with applicable pharmacopoeial requirements, validated sterilization or aseptic filling, extractables and leachables assessment, and transport stability Appropriate for high-volume hospital use where storage efficiency and low breakage risk are priorities
Supplier Profile 4 20% and 40% dextrose injection Emergency correction of severe hypoglycemia and selected intensive-care applications Intravenous use by trained healthcare professionals with glucose monitoring and assessment of vascular access Highly hypertonic formulations; require precise dosing, careful infusion control, and monitoring for hyperglycemia or local tissue injury Unit-dose ampoules, vials, or small-volume bags designed for emergency medication storage Tight control of assay, osmolality, pH, particulate matter, sterility, endotoxins, and dose-delivery accuracy Prioritize suppliers with reliable emergency stock, clear strength labeling, and packaging that minimizes selection errors
Supplier Profile 5 5%, 10%, 20%, and specialty hospital presentations General fluid therapy, perioperative support, nutritional carbohydrate supply, and pharmacy-compounded treatment protocols when clinically appropriate Intravenous infusion; use depends on patient age, renal function, glucose status, and required carbohydrate delivery A preservative-free, clear solution is typical; formulations should be compatible with the intended administration system and storage conditions A range of bottle, bag, vial, and ampoule formats for central pharmacy and ward supply Good manufacturing practice, batch traceability, validated shelf life, temperature-controlled logistics when required, and documented product specifications Useful for buyers seeking a broad portfolio, flexible pack sizes, and dependable supply continuity without relying on a single presentation

Note: Product strength, route, packaging, labeling, and approved indications vary by jurisdiction and product dossier. Clinical use should follow the applicable prescribing information and professional medical guidance.

Quality, Safety, and Regulatory Requirements

Choosing the five best anhydrous dextrose injection suppliers requires more than comparing prices. Quality begins with validated sterile processing, accurate concentration, and reliable container closure systems. For Dexona Injection, buyers should verify the manufacturing site, batch number, expiry date, and certificate of analysis. USP and relevant pharmacopeial standards support controls for sterility, endotoxins, particulate matter, and assay accuracy. Small details matter. A cloudy solution is unacceptable.

The World Health Organization estimates that one in ten medical products in low- and middle-income countries may be substandard or falsified. This finding makes supplier qualification essential. FDA guidance also emphasizes data integrity, complete batch records, and traceable laboratory results. Suppliers should provide evidence of GMP compliance, validated sterilization, stability studies, and temperature-controlled distribution. EU GMP Annex 1 further expects contamination-control strategies for sterile manufacturing. A polished certificate alone is not enough. I would not treat documentation as proof without checking its consistency.

Tips:

Request three recent batch records, not one. Confirm endotoxin limits, fill volume, and storage conditions. Inspect tamper-evident packaging and shipping temperature logs. Ask whether deviations were investigated and closed. Supplier audits should include the warehouse, laboratory, and contract manufacturers. Independent testing can reveal concentration errors or unexpected particles. This step costs more, but skipping it may cost far more.

How to Evaluate Global Suppliers

How to Evaluate Global Suppliers

Selecting an anhydrous dextrose injection supplier requires more than comparing prices. Confirm whether the company manufactures the finished sterile injection or only supplies pharmaceutical-grade powder. Review GMP certificates, inspection history, deviation records, and recent batch documentation. The FDA’s Drug Shortages Task Force report (2019) found that 62% of shortages involved product-quality problems. This makes quality systems a commercial concern, not only a regulatory requirement.

Request evidence for assay, sterility, bacterial endotoxins, particulate matter, pH, and container-closure integrity. WHO Technical Report Series No. 986, Annex 2, stresses validated sterile-processing controls and contamination prevention. Check whether testing is performed by qualified laboratories with traceable methods. Ask for stability data under the temperatures used during shipping and storage. Logistics matter. A supplier with strong production may still fail during customs delays or regional distribution.

Tips: Build a weighted scorecard covering quality, regulatory readiness, capacity, delivery history, and business continuity. Verify references independently, and conduct a remote or onsite audit when possible. A low quotation can hide weak documentation. No scorecard is perfect. Recheck assumptions after the first three commercial batches, especially complaint response time, fill-volume consistency, and deviation transparency. Supplier performance should be measured, not simply promised.

5 Best Anhydrous Dextrose Injection Suppliers Worldwide: How to Evaluate Global Suppliers

This chart presents a 100-point due-diligence framework for comparing global anhydrous dextrose injection suppliers. Quality-system compliance and product quality receive the highest weighting because sterile injectable medicines require validated manufacturing, documented testing, sterility assurance, and regulatory control. The values are evaluation weights rather than performance claims about any specific company or brand.

Five Leading Anhydrous Dextrose Injection Suppliers

The five leading anhydrous dextrose injection suppliers usually share strong sterile-manufacturing experience. They support hospitals, clinics, and approved pharmaceutical distributors. Their facilities should follow recognized GMP standards and maintain clear batch records. A reliable supplier provides certificates of analysis, sterility results, endotoxin data, and stability information. These documents matter during clinical purchasing and regulatory review.

The first supplier type is a specialized sterile-injection manufacturer with dedicated filling lines. The second is a hospital distributor offering controlled storage and documented delivery. The third is a contract manufacturer with flexible batch sizes and validated packaging. The fourth serves regional markets and manages import documentation carefully. The fifth focuses on cold-chain logistics, shipment monitoring, and rapid replacement procedures. Each supplier needs practical quality controls, not only attractive sales material.

Look beyond the brochure.

During evaluation, request sample labels, carton photographs, lot traceability, and temperature records. Confirm that the container closure protects the solution during transport and storage. Procurement teams may also encounter searches involving Injection Metrogyl, so product identity must be checked carefully. Similar wording can create costly selection errors. No supplier is flawless. Delivery delays, incomplete documents, or unclear communication may still occur. A small pilot order can reveal these weaknesses before a larger hospital contract begins.

Ordering, Storage, and Supply Chain Considerations

5 Best Anhydrous Dextrose Injection Suppliers Worldwide

Ordering, Storage, and Supply Chain Considerations

Choosing among leading anhydrous dextrose injection suppliers requires more than comparing prices. Review manufacturing licenses, sterile-filling controls, batch-release testing, and documented temperature records. WHO Technical Report Series No. 1025, Annex 9, stresses validated storage, transport, and distribution practices for medical products. Ask suppliers for stability data, container specifications, and certificates of analysis before placing volume orders. A cheaper quotation can hide higher inspection and replacement costs.

Demand planning should reflect hospital usage, seasonal admissions, and emergency reserves. The IQVIA Institute’s Global Use of Medicines 2024 report projects worldwide medicine spending will approach 2.3 trillion dollars by 2028. That growth may increase pressure on injectable supply networks. Store products under the labeled conditions, protect cartons from sunlight, and use calibrated data loggers during transit. Never assume dextrose injection follows the same conditions as Vitamin C Injection. Product specifications differ.

Tips: Use two qualified supply sources when possible. Set reorder points by actual consumption, not optimism. Check vial seals and solution clarity on arrival. Record lot numbers, delivery temperatures, and expiry dates. WHO guidance supports temperature mapping, yet many smaller facilities still rely on one wall thermometer. That is not enough. I have seen spreadsheets look complete while a receiving gap remained unresolved. Review the process honestly. Supplier performance should include delivery accuracy, complaint response time, and recall communication, not only unit cost.

Lincomycin Hydrochloride for Injection: Safety, Applications & Market Trends—WHO and IQVIA Report Insights

Lincomycin hydrochloride for injection is a bacteriostatic antibiotic containing lincomycin. It is supplied as a clear, colorless or nearly colorless solution, with a single-dose specification of 60 mg and a 24-month validity period when sealed and stored below 25°C. It may be used against susceptible staphylococci, streptococci, pneumococci, and anaerobic bacteria associated with respiratory, skin and soft-tissue, female reproductive tract, pelvic, or abdominal infections. Treatment should be based on clinical assessment and, where appropriate, antimicrobial susceptibility testing.

For adults, the usual intramuscular dose is 600 mg twice daily. Intravenous administration requires dilution in 100–200 ml of fluid and infusion over 1–2 hours, generally every 8–12 hours; pediatric dosing is weight-based and must be determined by a qualified clinician. Important risks include nausea, diarrhea, pseudomembranous enteritis, blood-count abnormalities, allergic reactions, and severe cardiovascular events if infused too rapidly. It is contraindicated in patients allergic to lincomycin or clindamycin, while extra caution is needed with intestinal disease or impaired liver or kidney function.

From a WHO antimicrobial-stewardship perspective, appropriate prescribing, infection confirmation, and monitoring for resistance remain central to responsible use. IQVIA-style market analysis can help assess demand, hospital procurement, regional access, and changing treatment patterns, but market growth should not replace evidence-based prescribing. During therapy, increased stool frequency requires prompt evaluation, and treatment should be discontinued when clinically indicated.

FAQS

What is anhydrous dextrose injection?

It is a sterile intravenous solution containing glucose without bound water molecules. It provides rapidly available carbohydrate through the bloodstream. It is not oral sugar water.

Which concentrations are commonly available?

Common strengths include 5%, 10%, and 50% solutions. A 5% solution provides about 170 kilocalories per liter. A 10% solution provides approximately 340 kilocalories.

Why do concentrated solutions require extra caution?

Higher concentrations are strongly hypertonic and may irritate veins. Leakage can injure surrounding tissue. Infusion access, dilution, and monitoring require careful review.

What quality documents should suppliers provide?

Request assay, sterility, endotoxin, particulate, pH, and container-closure test results. Also review batch records, stability data, and certificates of analysis. Missing documents deserve attention.

How can a buyer evaluate a supplier?

Review manufacturing licenses, sterile-processing controls, inspection history, and deviation records. Check delivery performance and complaint response times. Price alone is a weak measure.

What should be checked before placing a large order?

Confirm container specifications, temperature requirements, expiry dates, and batch-release testing. Ask for shipping stability data. A low quotation may hide replacement costs.

How should the product be stored and transported?

Follow the labeled storage conditions and protect cartons from sunlight. Use calibrated data loggers during transport. One wall thermometer is not enough.

What should a facility inspect when the shipment arrives?

Check seals, solution clarity, lot numbers, expiry dates, and recorded temperatures. Keep receiving records complete. A clear bag is not automatically safe.

Should healthcare facilities use more than one supplier?

Two qualified sources can reduce disruption risk when practical. Set reorder points from real consumption and emergency needs. My checklist could still miss a receiving gap.

How should supplier performance be reviewed after purchase?

Reassess performance after the first three commercial batches. Measure fill-volume consistency, delivery accuracy, complaint handling, and recall communication. Promises are not performance.

Conclusion

Anhydrous Dextrose Injection is a sterile intravenous solution containing dextrose in a water-free form, designed to provide rapidly available glucose and fluid support in appropriate clinical settings. Its medical uses may include supplying energy, supporting blood glucose management, and assisting with fluid replacement when prescribed by qualified healthcare professionals. Formulation characteristics such as concentration, sterility, compatibility, packaging, and stability are essential to safe and effective use.

When selecting a global supplier, buyers should assess manufacturing quality systems, regulatory compliance, product documentation, batch consistency, and capacity to meet healthcare requirements. Reliable suppliers should provide clear certificates of analysis, validated sterilization information, traceability, and suitable packaging. Ordering decisions should also consider minimum quantities, lead times, transportation conditions, storage temperature, shelf life, and contingency planning. Careful evaluation of these factors helps healthcare organizations obtain consistent, compliant products while maintaining product integrity throughout the supply chain.

Amelia

Amelia

Amelia is a seasoned marketing professional with nearly a decade of experience specializing in the export of biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts. Her profound industry knowledge allows her to......
Previous What Are the Top Types of Veterinary Injections in 2026?